menu ☰
menu ˟

First patient enrolled in phase 4 trial for Sjögren’s dry eye

18 Apr 2018
Wize Pharma Inc. announced it has enrolled the first patient in its phase 4 clinical trial in Israel for LO2A for the symptomatic treatment of dry eye syndrome in patients with Sjögren’s syndrome.The randomized, double-masked study will evaluate L...

Click here to view the full article which appeared in Optometry

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.